Internal Medicine · Philadelphia, PA
NPI
1811378276
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3401 N Broad St
Philadelphia, PA, 19140
Phone (215) 707-5734
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
358 services
Medicare patients, 2024
184
Average age 65
Drug cost, 2024
$1.3M
1,720 prescriptions
Company payments, 2024
$361
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Haynes was code 95720 (neurologic), 73 times for 32 patients. In total Jennifer M Haynes billed 358 services in 24 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 73 | 32 | $156.39 | $11K |
| 99214 Office E&M - Established | Facility | 47 | 42 | $66.66 | $3,133 |
| 99214 Office E&M - Established | Office | 25 | 22 | $76.09 | $1,902 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 11 | $60.03 | $1,441 |
| 95718 Neurologic | Facility | 19 | 19 | $101.42 | $1,927 |
| 99213 Office E&M - Established | Facility | 17 | 17 | $41.95 | $713 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $99.25 | $1,389 |
| 95819 Neurologic | Facility | 11 | 11 | $43.04 | $473 |
By year: 2022 $22K for 264 services; 2023 $29K for 361 services; 2024 $29K for 358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Haynes prescribed most often to Medicare patients was Levetiracetam, with 174 prescriptions and refills. In total Jennifer M Haynes wrote 1,720 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 174 | 367 | 48 | $5,946 |
| Clobazam Generic | 142 | 152 | 13 | $25K |
| Lacosamide Generic | 140 | 184 | 22 | $19K |
| Briviact Brivaracetam | 115 | 144 | 17 | $267K |
| Zonisamide Generic | 79 | 164 | 18 | $2,851 |
| Xcopri Cenobamate | 79 | 118 | 11 | $154K |
| Clonazepam Generic | 75 | 94 | 20 | $850 |
| Lamotrigine Generic | 75 | 145 | 15 | $1,225 |
| Topiramate Generic | 73 | 151 | 19 | $1,495 |
| Divalproex Sodium Er Divalproex Sodium | 48 | 103 | Under 11 | $5,052 |
| Divalproex Sodium Generic | 45 | 68 | Under 11 | $3,784 |
| Levetiracetam Er Levetiracetam | 40 | 80 | 11 | $4,353 |
| Nayzilam Midazolam | 38 | 42 | 27 | $64K |
| Citalopram Hbr Citalopram Hydrobromide | 36 | 37 | Under 11 | $506 |
| Oxcarbazepine Generic | 33 | 59 | Under 11 | $3,627 |
Brand drugs: 480 claims; generic drugs: 1,209 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jennifer M Haynes $361 ($361 in general payments such as food, travel and fees) from 2 companies. The largest payer was UCB, Inc. with $263.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.